# Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors

> **NCT01222546** · PHASE1 · COMPLETED · sponsor: **Chugai Pharma Europe Ltd.** · enrollment: 38 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** CH5132799

## Key facts

- **NCT ID:** NCT01222546
- **Lead sponsor:** Chugai Pharma Europe Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-11
- **Final completion:** 2012-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2014-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01222546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01222546, "Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01222546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*